Converge Bio Secures $25 Million Funding to Revolutionize Drug Discovery with Generative AI Converge Bio has raised $25 million in Series A funding to enhance drug discovery in biotechs and pharmaceutical companies with AI innovation.

Converge Bio Secures $25 Million Funding to Revolutionize Drug Discovery with Generative AI #USA #Generative_AI #Boston #Drug_Discovery #Converge_Bio